志道國際(01220.HK):已與專業顧問就可行復牌計劃進行討論 繼續停牌
格隆匯10月10日丨志道國際(01220.HK)發佈公告,公司已與專業顧問討論,以就制定針對復牌指引可行復牌計劃書探索及考慮可供公司選擇方案。隨着建築業務持續擴展以及存在潛在業務收購及投資商機,集團計劃在其未來財務狀況反映集團遵守上市規則第13.24條的情況,顯示具有充足營運及資產支持其上市地位,繼而恢復股份買賣。
公司股份將繼續於聯交所暫停買賣,以待達成復牌指引。公司將遵照上市規則於適當時間及至少每季向其股東及公眾提供有關其業務營運發展、復牌計劃及預期時間表的最新進展、執行復牌計劃的進度(及其任何重大變動)以及任何其他相關事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.